Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Milsing d.o.o. |
---|---|
Information provided by: | Milsing d.o.o. |
ClinicalTrials.gov Identifier: | NCT00460538 |
The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms.
Condition | Intervention | Phase |
---|---|---|
Seasonal Allergic Rhinitis |
Dietary Supplement: Lectranal Dietary Supplement: placebo |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms |
Enrollment: | 48 |
Study Start Date: | April 2007 |
Study Completion Date: | November 2007 |
Primary Completion Date: | October 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
2: Placebo Comparator |
Dietary Supplement: placebo
Dosage form: capsule 2: Dosage: 2 capsules Frequency and duration: 2 times daily over the 6 weeks
|
1: Active Comparator |
Dietary Supplement: Lectranal
Dosage form: capsule 1: Dosage: 2 capsule Frequency and duration: 2 times daily over the 6 weeks |
Patients allergic to the specific pollen are divided into two groups randomly. One group is being administered Lectranal and the other group is being administered placebo during the period of 6 weeks in season of the pollen. Methods used for evaluation are: SARS questionnaire(seasonal allergic rhinitis symptoms), Mini RQLQ (mini rhinoconjunctivitis quality of life questionnaire) skin Prick test, specific IgE and IgG, eosinophilia in nasal secretion. Methods used for follow up safety include side effects report, physical examination and vital signs.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Dubrava University Hospital, Zagreb, Croatia ( Neven Tudoric MD PhD ) |
Study ID Numbers: | MIL-002 |
Study First Received: | April 13, 2007 |
Last Updated: | December 28, 2007 |
ClinicalTrials.gov Identifier: | NCT00460538 |
Health Authority: | Republic of Croatia: Ethic Committee of Dubrava University Hospital |
Seasonal allergic rhinitis lectranal allergy |
Hypersensitivity Otorhinolaryngologic Diseases Respiratory Tract Infections Respiratory Tract Diseases |
Rhinitis, Allergic, Seasonal Hypersensitivity, Immediate Rhinitis Respiratory Hypersensitivity |
Immune System Diseases Nose Diseases |